Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Stan Watowich | Ridgeline Therapeutics - Targeting Aging Biology and Chronic Disease
|
May 02, 2026 |
|
Michael Heltzen | eXoZymes – AI-Enabled Cell-Free Biomanufacturing and the Future of Enzyme Engineering
|
Apr 18, 2026 |
|
Charles Legg | CureLab Oncology – Advancing Immuno-Oncology Through Targeting the Tumor Microenvironment
|
Apr 07, 2026 |
|
Christopher Gropp | Trialogics – Modernizing Clinical Trials Through AI, Real-Time Data, and Integrated Technology
|
Mar 24, 2026 |
|
Chris Hoyt | KeifeRx – Building Biotech Companies Around Academic Drug Discovery
|
Mar 10, 2026 |
|
Ben Scruggs | Altis Biosystems – Engineering Predictive Human Gut Models for Drug Development
|
Feb 24, 2026 |
|
Murat Croci | Ibex Biosciences – Translating Breakthrough Science into Clinical-Stage Therapies
|
Feb 07, 2026 |
|
Gitte Pedersen | Genomic Expression – RNA Diagnostics and Transforming Precision Oncology
|
Jan 24, 2026 |
|
Jason Kralic | Tellus Therapeutics – Translational Biotech Platforms and Advancing Therapies for Neonatal Brain Injury
|
Jan 10, 2026 |
|
Karthik Sriram | Parabilis Medicines – Strategic Finance and the Helicon™ Platform Shaping the Future of Peptide Therapeutics
|
Dec 09, 2025 |
|
Jim Buck | Medcura – Advancing Surgical Safety Through Innovative Hemostatic Solutions
|
Oct 07, 2025 |
|
Mike Stocum | Bantam Pharmaceutical – Targeting Cancer Through the Mitochondria
|
Sep 22, 2025 |
|
Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics
|
Sep 08, 2025 |
|
Larry Tiffany | CEO, GenrAb – Developing Fully Human Neuroprotective Antibodies for Neurodegenerative Diseases
|
Sep 08, 2025 |
|
Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics
|
Sep 08, 2025 |
|
Darren Dasburg | CEO, Clarus Biologics – Advancing Vaccine and Immunology Innovation with Novel Adjuvant Platforms
|
Sep 08, 2025 |
|
Ayla Annac | CEO & Co-Founder, InvivoSciences – Precision Medicine for Heart Failure and Cardiometabolic Diseases
|
Sep 08, 2025 |
|
Anna Kazanchyan, MD | CEO, Saghmos Therapeutics – Cardiovascular and Kidney Protection with ST-62516
|
Sep 08, 2025 |
|
Charles Swindell | CEO, Glycotest – Advancing Glycoprotein Biomarkers for Liver Disease Detection
|
Sep 08, 2025 |
|
Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment
|
Sep 08, 2025 |
|
Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health
|
Sep 08, 2025 |